Dr. Reddys Fact Sheet, Dr. Reddys Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr. Reddys Fact Sheet    (REDY)


Discover: India's #1 Defence Stock


Here is the latest financial fact sheet of Dr. Reddys. For more details, see the Dr. Reddys quarterly results and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR. REDDYS LAB Price History

Price Rs 4,829.6
Mkt Cap Rs m 800,313
Vol '000 34.2
P/E X 51.1
P/CF X 25.8
EPS (TTM) Rs 94.5
% ch % -1.4
No. of shares m 165.71
% ch week % 2.6
% ch 1-mth % -3.0
% ch 12-mth % 62.7
52 week H/L Rs 5,514.7/2,497.6
(As on Nov 27, 2020 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR. REDDYS LAB Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
DR. REDDYS LAB EQUITY SHARE DATA
High Rs4,3833,3972,7882,8753,363 
Low Rs2,7502,5601,9021,8882,352 
Sales per share (Unadj.) Rs912.5856.5860.8930.21,054.2 
Earnings per share (Unadj.) Rs124.978.057.1117.4121.9 
Diluted earnings per shareRs128.678.057.1117.7122.3 
Cash flow per share (Unadj.) Rs179.9139.9122.0185.8190.2 
Dividends per share (Unadj.) Rs20.0020.0020.0020.0025.00 
Adj. dividends per shareRs20.5920.0020.0220.0425.07 
Dividend yield (eoy) %0.60.70.90.80.9 
Book value per share (Unadj.) Rs736.8739.8757.7844.4938.7 
Adj. book value per shareRs758.5740.0758.7846.3941.3 
Shares outstanding (eoy) m170.61165.74165.91166.07166.17 
Bonus/Rights/Conversions  ESOPBBESOPESOPESOP 
Price / Sales ratio x3.93.52.72.62.7 
Avg P/E ratio x28.638.241.120.323.4 
P/CF ratio (eoy) x19.821.319.212.815.0 
Price / Book Value ratio x4.84.03.12.83.0 
Dividend payout %16.025.735.017.020.5 
Avg Mkt Cap Rs m608,481493,632389,034395,496474,831 
No. of employees `00021.722.723.522.021.7 
Total wages/salary Rs m31,17431,06832,14933,56233,802 
Avg. sales/employee Rs Th7,184.66,259.06,070.87,032.88,091.0 
Avg. wages/employee Rs Th1,438.61,369.81,366.61,527.91,561.3 
Avg. net profit/employee Rs Th983.2569.7402.5887.7935.8 
DR. REDDYS LAB INCOME DATA
Net Sales Rs m155,683141,961142,810154,482175,170 
Other income Rs m2,9501,7151,5523,3756,206 
Total revenues Rs m158,633143,676144,362157,857181,376 
Gross profit Rs m35,85324,72223,51231,78224,421 
Depreciation Rs m9,38910,26610,77211,34811,348 
Interest Rs m826634788889983 
Profit before tax Rs m28,58815,53713,50422,92018,296 
Minority Interest Rs m00000 
Prior Period Items Rs m229349344438561 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m7,5112,9654,3803,858-1,403 
Profit after tax Rs m21,30612,9219,46819,50020,260 
Gross profit margin %23.017.416.520.613.9 
Effective tax rate %26.319.132.416.8-7.7 
Net profit margin %13.79.16.612.611.6 
DR. REDDYS LAB BALANCE SHEET DATA
Current assets Rs m117,94096,837104,984111,101125,991 
Current liabilities Rs m63,47184,19968,93858,97372,141 
Net working cap to sales %35.08.925.233.730.7 
Current ratio x1.91.21.51.91.7 
Inventory Days Days6073747973 
Debtors Days Days979810494105 
Net fixed assets Rs m73,352102,552104,385101,24583,854 
Share capital Rs m853829830830831 
"Free" reserves Rs m124,845121,792124,886139,406155,157 
Net worth Rs m125,698122,621125,716140,236155,988 
Long term debt Rs m10,6855,44925,08922,0001,304 
Total assets Rs m203,841218,165225,443224,656232,253 
Interest coverage x35.625.518.126.819.6 
Debt to equity ratio x0.100.20.20 
Sales to assets ratio x0.80.70.60.70.8 
Return on assets %10.96.24.59.19.1 
Return on equity %17.010.57.513.913.0 
Return on capital %21.712.99.714.912.6 
Exports to sales %46.654.6000 
Imports to sales %9.09.4000 
Exports (fob) Rs m72,61877,520000 
Imports (cif) Rs m14,05013,274000 
Fx inflow Rs m75,40581,67072,62388,67384,193 
Fx outflow Rs m27,11526,35518,91619,10439,616 
Net fx Rs m48,29055,31553,70769,56944,577 
DR. REDDYS LAB CASH FLOW
From Operations Rs m 32,626 21,444 18,030 28,704 29,841 
From Investments Rs m -20,394 -18,404 -14,883 -7,727 -4,923 
From Financial Activity Rs m -17,001 -3,692 -4,440 -21,326 -25,159 
Net Cashflow Rs m -474 -1,144 -1,236 -314 -266 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 25.5%
Foreign collaborators 0.0%
Indian inst/Mut Fund 5.4%
FIIs 35.3%
ADR/GDR 18.5%
Free float 15.3%
Shareholders 75,885
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034
E-MAIL spoddar@drreddys.com WEB www.drreddys.com
TELEPHONE (040) 4900 2222 FAX (040) 4900 2999
SECTOR PHARMACEUTICALS GROUP Dr. Reddy's Group
TR AGENT Bigshare Services Ltd., G-10, Left wing, Amrutha Ville, Hyderabad - 82
AUDITOR B. S. R & Co.
CHM: G. V. Prasad COMP SEC: Sandeep Poddar YEAR OF INC: 1984 BSE CODE: 500124 FV (Rs): 5 DIV YIELD (%): 0.5

More Pharmaceuticals Company Fact Sheets:   PROCTER & GAMBLE HEALTH  NOVARTIS  GLENMARK PHARMA  SUN PHARMA  NEULAND LABS  

Compare DR. REDDYS LAB With:   PROCTER & GAMBLE HEALTH  NOVARTIS  GLENMARK PHARMA  SUN PHARMA  NEULAND LABS  

Compare DR. REDDYS LAB With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Views on news

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

More Views on News

Most Popular

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB - FULFORD INDIA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS